Awards, papers and milestones.

1. 2026

   CytoHub receives the Impact Award at The AI Summit @ Stanford

   CytoHub was recognized with the Impact Award at The AI Summit @ Stanford.

   Award
2. Oct 2026

   Our founding lab defines “immunoids” in Cell Stem Cell

   The Aguirre Lab at MSU reviews immune-competent organoids and proposes the field’s first design standards. CardioVive’s heart immunoid is built on the same principles.

   Read the Perspective (open access)

   Publication
3. Jul 2026

   Stanford collaborators publish scVision, the foundation for CytoRNA-FM

   scVision is pre-trained without labels on 72 million public human cells and outperformed existing foundation models across six held-out studies. CytoHub is tuning it on CardioVive heart data as CytoRNA-FM.

   Read the preprint on arXiv

   Research
4. 2026

   Exclusive platform license executed with Michigan State University

   CytoHub holds the exclusive license to the human heart assembloid platform developed in the Aguirre Lab.

   Company
5. 2025

   Tissue-resident macrophages published in Cell Stem Cell

   Immune cells integrated into human heart tissue persist for more than 60 days and improve maturation.

   O’Hern et al. · Cell Stem Cell

   Publication
6. 2023

   Adult-grade heart tissue published in Nature Communications

   EMM2/1 maturation brings human heart tissue to adult-grade electrophysiology.

   Volmert et al. · Nature Communications

   Publication

Press enquiries: contact us.